Dr. Kirsh Discusses the Future of Treating Prostate Cancer

Gary Kirsh, MD, president of The Urology Group and the Large Urology Group Practice Association (LUGPA), discusses the future of treatment for prostate cancer.

Localized prostate cancer continues to be treated using robotic surgery and radiation therapy, but advancements have recently been made in treatment for advanced prostate cancer.

Several agents have been approved since 2010 for advanced prostate cancer, including immunotherapy, targeting agents, and hormonal therapy. Additional agents are also anticipated to be approved soon, Kirsh adds.

In the future, Kirsh says that he sees urologists being increasingly involved in advanced prostate cancer. Urologists in LUGPA have the wherewithal and infrastructure to put together pathways and algorithms for prostate cancer treatments, Kirsh says.